The Current Role of Platelet-Active Drugs in Ischaemic Heart Disease
- 1 May 1991
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 41 (5), 665-671
- https://doi.org/10.2165/00003495-199141050-00001
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- DipyridamoleNew England Journal of Medicine, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- A Controlled Comparison of Aspirin and Oral Anticoagulants in Prevention of Death after Myocardial InfarctionNew England Journal of Medicine, 1982
- Coronary Vasoconstrictor Effect of Indomethacin in Patients with Coronary-Artery DiseaseNew England Journal of Medicine, 1981
- Thromboxane A2in Vasotonic Angina PectorisNew England Journal of Medicine, 1981